510(k) K984530
K984530 is an FDA 510(k) premarket notification submitted by Metrika, Inc. for the device "DRX NTX OR, OSTEOMARK NTX DIRECT RESPONSE". The FDA issued a decision of Substantially Equivalent on August 10, 1999. The device falls under product code JFY (Enzymatic Method, Creatinine), a Class II device regulated under 21 CFR 862.1225. Metrika, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 10, 1999
- Date Received
- December 21, 1998
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzymatic Method, Creatinine
- Device Class
- Class II
- Regulation Number
- 862.1225
- Review Panel
- CH
- Submission Type